Medical Cannabis Studies


• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)


• batten-disease (6)

• benefits (9)

• breast-cancer (7)


• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)


• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)


• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)


• fibromyalgia (2)

• fibrosis (1)


• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)


• health-care (1)

• hiv (7)

• huntingtons-disease (1)


• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)


• krabbe-disease (4)


• liver (2)

• lung-cancer (2)

• lupus (1)


• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)


• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)


• pain (29)

• pancreatitis (1)

• prostate-cancer (2)


• schizophrenia (2)

• skin (1)

• sports (3)


• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation (2000)

    THC (the main component of cannabis) induces apoptosis (cell death) of cancer cells in culture. Its intratumoral administration induced a considerable regression of malignant gliomas. View study

  • Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy (2007)

    Anandamide is potentially involved in the control of cancer growth directed both to the proliferation of tumor cells and to the angiogenic stimulation of the vasculature. View study

  • Antibacterial Cannabinoids from Cannabis sativa: A Structure-Activity Study (06/01/05)

    Marijuana contains antibacterial cannabinoids whose potential to address antibiotic resistance. The five major cannabinoids: cannabidiol CBD, cannabicyromen, cannabigerol, THC, and cannabinol showed potent activity against a variety of methicillin-resistant strains of Staphylococcus aureus. View study

  • Anticancer mechanisms of cannabinoids (2016)

    There is a lot of evidence that shows how cannabinoids can reduce cancer tumors in animals. These findings already serve as the basis for the development of studies that analyze the therapeutic potential of cannabinoids to fight cancer. View study

  • Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa (2014)

    Cannabidiol (CBD) is a non-psychotomimetic component of Cannabis sativa with great psychiatric potential, which includes its use as an antidepressant and anxiolytic compound. Studies with animal models, which perform a myriad of experiments, suggest that CBD exhibited anxiety and antidepressant effects. View study

  • Antimicrobial Activity of Cannabis sativa L. (2011)

    In the present study, the oil of the seeds, the petroleum ether and the methanol extracts of the whole plant of Cannabis sativa were tested against various organisms and fungi, demonstrating important microbial properties. View study

  • Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma (2006)

    A comparison of antitumor properties of different cannabinoids. The results obtained show that cannabidiol is the most potent inhibitor of the growth of cancer cells. View study

  • Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines (2004)

    In this study, the in vitro antiproliferative capacity of cannabidiol (CBD), a non-psychoactive cannabinoid compound, in U87 and U373 human glioma cell lines is evaluated. According to the results obtained, it could be concluded that non-psychoactive CBD was able to produce significant antitumor activity both in vitro and in vivo, suggesting a possible application of CBD as an antineoplastic agent View study

  • Antitumorigenic Effects of Cannabinoids beyond Apoptosis (2009)

    Cannabinoids may likewise affect cancer cell angiogenesis, migration, invasion, adhesion, and metastasization. View study

  • Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments (2014)

    Effectiveness of the instruments for the detection and evaluation of cannabis use disorders. View study

  • Assessment of the role of CB receptors in cannabinoid 1 anticonvulsant effects (2001)

    It has been shown that cannabinoids are anticonvulsants in the maximum electroshock. This study establishes a role for the CB1 receptor in modulating convulsive activity in an animal model. View study

  • Association of Herbal Cannabis Use With Negative Psychosocial Parameters in Patients With Fibromyalgia (2009)

    This research is based on the association of the use of herbal cannabis with negative psychosocial parameters in patients with fibromyalgia. It was concluded in this investigation that cannabinoids were used by 13% of patients referred with a diagnosis of fibromyalgia (FM). The association of the use of herbal cannabis with negative psychosocial parameters raises questions about the reason for this practice of self-medication. Although cannabinoids may offer some therapeutic effect, caution should be exercised with regard to any recommendation pending clarification of general health and psychosocial problems, especially for those who self-medicate. View study